ARLO vs PLPC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ARLO exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to assess bankruptcy risk. While the company shows strong recent earnings growth and beats on earnings surprises, profitability remains thin with negative ROA and elevated valuation multiples. The stock trades significantly above its Graham Number of $0.91 and intrinsic value of $0.21, suggesting substantial premium pricing. Analysts maintain a strong_buy recommendation, but insider selling worth $17.9M over the past six months raises caution, offsetting bullish sentiment.
PLPC exhibits a severe valuation disconnect, with a current price of $298.51 trading significantly above its Graham Number ($124.85) and Intrinsic Value ($50.05). While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is exceptionally clean (Debt/Equity 0.10), these fundamentals do not support the current P/E of 41.75. The combination of negative earnings growth (-19.20%) and a bearish technical trend (10/100) suggests the stock is currently in a bubble phase following a massive 1-year run-up.
Compare Another Pair
Related Comparisons
ARLO vs PLPC: Head-to-Head Comparison
This page compares Arlo Technologies, Inc. (ARLO) and Preformed Line Products Company (PLPC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.